Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Study formulation** is an investigational, lipid-based multi-ingredient nutraceutical developed for adults at risk of type 2 diabetes. The once-daily oral formulation combines punicic acid-rich pomegranate seed oil, palmitoleic acid-rich buckthorn oil, pinolenic acid-rich pine nut oil, curcumin, chromium picolinate, and the plant sterol campesterol. In an 8-week randomized pilot study, it was evaluated at doses of 3.5 mL and 7 mL daily for effects on insulin sensitivity, glucose tolerance, abdominal adiposity, inflammation, and metabolic hormones. The formulation has no established single molecular target; its proposed effects reflect complementary actions of its fatty-acid, polyphenol, trace-element, and plant-sterol constituents on insulin signaling, nutrient metabolism, inflammation, and gastrointestinal hormone secretion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on study formulation.